Accumulation of GSK ‐3β in Interneurons Impairs Adult Hippocampal Neurogenesis by Inhibiting GABAergic Transmission
Aging Cell · 2025
DOI: 10.1111/acel.70115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2025. Verfasst von Fei Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Anatomy, School of Basic Medicine, Binzhou Medical University, Yantai, China. Hauptthemen laut MEDLINE: Glycogen Synthase Kinase 3 beta, Neurogenesis, Interneurons, Hippocampus. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shandong Provincial Natural Science Foundation, Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
The activation of glycogen synthase kinase 3β (GSK‐3β) and the deterioration of spatial memory represent prominent pathological and clinical manifestations of Alzheimer's disease (AD). Nevertheless, the precise intrinsic mechanisms linking these pathological features remain poorly elucidated. In this study, we identified significant upregulation of GSK‐3β activity in inhibitory interneurons within the hippocampal dentate gyrus (DG) of 3×Tg‐AD mice. Subsequent investigations demonstrated that targeted overexpression of GSK‐3β in these interneurons triggered aberrant activation of neural stem cells (NSCs), culminating in apoptotic cell death and consequent deficits in adult hippocampal neurogenesis (AHN). Utilizing in vivo fiber‐optic recording techniques, we further established that GSK‐3β overexpression in DG inhibitory interneurons elicited hyperactivation of excitatory neurons, thereby disrupting the excitation–inhibition (E/I) balance within the DG circuitry. Notably, these pathological alterations were ameliorated through chemogenetic suppression of excitatory neuronal activity. Mechanistically, we determined that impaired GABAergic transmission, characterized by reduced GABA release in the DG region, underlies these observed effects. Pharmacological intervention with GABA receptor agonists effectively rescued AHN impairment and attenuated spatial cognitive deficits. Collectively, these findings demonstrate that GSK‐3β overexpression in GABAergic interneurons compromises AHN and promotes NSC apoptosis via disruption of GABAergic signaling, while pharmacological potentiation of GABAergic transmission exerts neuroprotective effects. This study elucidates a previously unrecognized mechanism contributing to AHN impairment in AD and identifies a promising therapeutic target for pro‐neurogenic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Anatomy, School of Basic Medicine, Binzhou Medical University, Yantai, China.
- School of Rehabilitation Medicine, Binzhou Medical University, Yantai, China.
- Laboratory of Human Anatomy and Histo-Embryology, Binzhou Medical University, Yantai, China.
ORCID-Profile: Fei Liu
Förderung
- Shandong Provincial Natural Science Foundation
- Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China
Zitieren
APA
Liu, F., Cui, J. J., Li, X. L., Zhang, Z. M., Liang, S. H., Sun, Y., Li, J. M., Qu, H. L., Ye, J., Guo, Q. P., Zheng, Q., & Liu, Y. F. (2025). Accumulation of GSK ‐3β in Interneurons Impairs Adult Hippocampal Neurogenesis by Inhibiting GABAergic Transmission. Aging Cell. https://doi.org/10.1111/acel.70115
Vancouver
Liu F, Cui JJ, Li XL, Zhang ZM, Liang SH, Sun Y, et al. Accumulation of GSK ‐3β in Interneurons Impairs Adult Hippocampal Neurogenesis by Inhibiting GABAergic Transmission. Aging Cell. 2025. doi:10.1111/acel.70115
BibTeX
@article{Liu2025,
author = {Liu, Fei and Cui, Jiu-Jing and Li, Xiao-Lin and Zhang, Zeng-Min and Liang, Shao-Hua and Sun, Yi and Li, Jing-Min and Qu, Hong-Lin and Ye, Jing and Guo, Qi-Peng and Zheng, Quan and Liu, Yong-Feng},
title = {Accumulation of GSK ‐3β in Interneurons Impairs Adult Hippocampal Neurogenesis by Inhibiting GABAergic Transmission},
journal = {Aging Cell},
year = {2025},
doi = {10.1111/acel.70115}
}
EUVIMED